Sio Gene Therapies Inc.
SIOXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SIOX. That does not mean none is planned.
Get an email about SIOX's next catalysts
Track Sio Gene Therapies (SIOX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AAV9-GLB1 | Phase 2 | Lysosomal Diseases | - | - |
Frequently asked questions
What is in Sio Gene Therapies Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in Sio Gene Therapies Inc.'s (SIOX) pipeline across Phase 2. Its lead program is AAV9-GLB1 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Sio Gene Therapies Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Sio Gene Therapies Inc. (SIOX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track SIOX biotech catalysts?β
Add SIOX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Sio Gene Therapies Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
